Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Baxter
Mallinckrodt
Healthtrust
Julphar
Express Scripts
McKesson
UBS
Cerilliant
AstraZeneca

Generated: February 23, 2018

DrugPatentWatch Database Preview

TEMOZOLOMIDE Drug Profile

« Back to Dashboard

Which patents cover Temozolomide, and when can generic versions of Temozolomide launch?

Temozolomide is a drug marketed by Accord Hlthcare, Amerigen Pharms Ltd, Amneal Pharms, Barr, Chemi Spa, Deva Holding As, Idt Australia Ltd, Kremers Urban Pharms, Mylan Pharms Inc, Rising Pharms Inc, Sun Pharma Global, Watson Labs Teva, and Zydus Pharms Usa Inc. and is included in thirteen NDAs.

The generic ingredient in TEMOZOLOMIDE is temozolomide. There are sixteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the temozolomide profile page.
Drug patent expirations by year for TEMOZOLOMIDE
Pharmacology for TEMOZOLOMIDE
Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity

US Patents and Regulatory Information for TEMOZOLOMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc TEMOZOLOMIDE temozolomide CAPSULE;ORAL 206750-001 Jul 31, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Idt Australia Ltd TEMOZOLOMIDE temozolomide CAPSULE;ORAL 206413-005 Apr 12, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Deva Holding As TEMOZOLOMIDE temozolomide CAPSULE;ORAL 207658-002 Apr 26, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc TEMOZOLOMIDE temozolomide CAPSULE;ORAL 205227-001 Jun 29, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Rising Pharms Inc TEMOZOLOMIDE temozolomide CAPSULE;ORAL 206309-006 Apr 27, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Kremers Urban Pharms TEMOZOLOMIDE temozolomide CAPSULE;ORAL 203898-003 Feb 10, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc TEMOZOLOMIDE temozolomide CAPSULE;ORAL 205227-002 Jun 29, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Rising Pharms Inc TEMOZOLOMIDE temozolomide CAPSULE;ORAL 206309-001 Apr 27, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharma Global TEMOZOLOMIDE temozolomide CAPSULE;ORAL 201742-001 Feb 12, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Chemi Spa TEMOZOLOMIDE temozolomide CAPSULE;ORAL 204639-004 Nov 23, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Argus Health
Teva
Colorcon
Accenture
Johnson and Johnson
AstraZeneca
Chubb
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot